Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal gangliosides are sialic acid-containing glycosphingolipids that are highly enriched in the outer leaflet of neuronal membranes, particularly at the presynaptic terminals of cholinergic neurons (Schengrund, 2015). They function as essential components of the dual-receptor mechanism for clostridial neurotoxins, such as Botulinum neurotoxin (BoNT) and Tetanus neurotoxin (TeNT) (Rummel, 2016). In this mechanism, the toxin's heavy chain first binds to gangliosides like GT1b or GD1a, which anchors the toxin to the membrane and facilitates its subsequent binding to high-affinity protein receptors like Synaptotagmin or SV2 (Dong et al., 2003). This interaction is a prerequisite for the endocytosis of the toxin and the subsequent cleavage of SNARE proteins, which inhibits acetylcholine release and leads to flaccid paralysis (Pirazzini et al., 2017). Beyond their role as toxin receptors, gangliosides are involved in modulating ion channels, cell signaling, and maintaining the stability of lipid rafts (Willison & Yuki, 2002). They are also clinically significant as targets for autoantibodies in autoimmune peripheral neuropathies, such as Guillain-Barré and Miller Fisher syndromes (Yuki & Hartung, 2012).
Neuronal gangliosides serve as the initial binding site for clostridial neurotoxins (dual-receptor model), where they concentrate the toxin on the presynaptic membrane to facilitate binding to high-affinity protein receptors (e.g., SV2 or synaptotagmin) for internalization (Rummel, 2016).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal ganglioside.